Follicle Stimulation / Ovulation Induction
Follicle stimulation, also called ovulation induction, refers to the use of pharmacological agents to recruit follicle development and support ovulation in cycles where the natural process is absent or inadequate. These agents are what patients commonly call fertility medications or fertility drugs. Two principal classes are used: oral agents, including clomiphene citrate (a selective estrogen receptor modulator) and letrozole (an aromatase inhibitor); and injectable gonadotropins, preparations containing FSH alone or FSH combined with LH.1 The appropriate agent class depends on the underlying ovulatory disorder, the clinical method being applied, and how the patient's cycle is being monitored.2 A 2014 randomized trial in the New England Journal of Medicine found letrozole superior to clomiphene for live birth rates in women with PCOS-related anovulation.3
Before these fertility medications are considered, a restorative evaluation asks why ovulation is not occurring. Anovulatory cycles have distinct causes: insulin resistance and PCOS, thyroid dysfunction, hyperprolactinemia, hypothalamic dysfunction from stress or low body weight, and others.4 Cycle charting via a fertility awareness-based method supplies the longitudinal picture that a single hormone draw cannot.5 Correcting the underlying metabolic cause, such as insulin resistance in PCOS treated with an insulin sensitizer, can restore spontaneous ovulation without requiring dedicated ovulation-stimulation agents such as clomiphene or gonadotropins.26 When stimulation is indicated, named methods like NaProTechnology select the agent and the monitoring approach based on the specific ovulatory disorder rather than applying a one-size protocol.7
Cycle monitoring during stimulation is standard. A follicle maturation study tracks follicle growth, identifies poor response early, and guides the decision to add an HCG trigger.8 Monitoring also reduces the risk of several follicles maturing at once.9 Restorative protocols aim for a single, well-developed follicle, favoring singleton pregnancies over multiples.10 Retrieval-based protocols recruit many follicles by design, because the eggs are collected rather than ovulated.
Controlled ovarian stimulation used in ART protocols recruits multiple follicles for egg collection rather than ovulation. The agent names may be the same, but doses in retrieval-based stimulation are substantially higher because the objective is collection, not supporting a single ovulatory event for the couple.11 The restorative aim is a single, well-timed ovulation. See IVF vs. RRM for a direct comparison of these paradigms. Retrieval-based stimulation bypasses the process that failed without resolving why it failed.10
Cited in this entry
- Quaas AM, Legro RS Pharmacology of medications used for ovarian stimulation. Best practice & research. Clinical endocrinology & metabolism. 2019. https://pubmed.ncbi.nlm.nih.gov/30470497/
- Balen AH, Morley LC, Misso M, Franks S, Legro RS, Wijeyaratne CN et al. The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance. Human reproduction update. 2016. https://pubmed.ncbi.nlm.nih.gov/27511809/
- Legro RS et al. Letrozole versus clomiphene for infertility in the polycystic ovary syndrome. N Engl J Med. 2014. https://rrmacademy.org/library/letrozole-or-clomiphene-for-infertility-in-the-polycystic-ovary-syndrome-recgrvvtlvs9dogjt/
- Concepción-Zavaleta MJ, Coronado-Arroyo JC, Quiroz-Aldave JE, Durand-Vásquez MDC, Ildefonso-Najarro SP, Rafael-Robles LDP et al. Endocrine factors associated with infertility in women: an updated review. Expert review of endocrinology & metabolism. 2023. https://pubmed.ncbi.nlm.nih.gov/37702309/
- Hilgers TW The Identification of Postovulation Infertility with the Measurement of Early Luteal Phase (Peak Day +3) Progesterone Production. The Linacre quarterly. 2020. https://pubmed.ncbi.nlm.nih.gov/32431450/
- Costello MF, Eden JA A systematic review of the reproductive system effects of metformin in patients with polycystic ovary syndrome. Fertility and sterility. 2003. https://pubmed.ncbi.nlm.nih.gov/12524053/
- Hilgers TW. Chapter 46: Medical Treatment of Ovarian Dysfunction. In: The Medical and Surg. https://rrmacademy.org/library/chapter-46-medical-treatment-of-ovarian-dysfunction/
- Hilgers TW. Chapter 22: Disorders of Human Ovulation: Clinical Validation of the Sonograph. https://rrmacademy.org/library/chapter-22-disorders-of-human-ovulation-clinical-validation-of-the-sonographic/
- Child TJ, Barlow DH Strategies to prevent multiple pregnancies in assisted conception programmes. Bailliere's clinical obstetrics and gynaecology. 1998. https://pubmed.ncbi.nlm.nih.gov/9930294/
- Boyle PC, de Groot T, Andralojc KM, Parnell TA. Healthy singleton pregnancies from restorative reproductive medicine (RRM) after failed IVF. Frontiers in Medicine. 2018. https://pubmed.ncbi.nlm.nih.gov/30109231/
- Huirne JA, Lambalk CB, van Loenen AC, Schats R, Hompes PG, Fauser BC et al. Contemporary pharmacological manipulation in assisted reproduction. Drugs. 2004. https://pubmed.ncbi.nlm.nih.gov/14871171/
Authoritative References
How other clinical authorities define this term. RRM Academy curates these verbatim or under fair use so the medical consensus is visible alongside our RRM-contextualized definition above.
- MeSH D010062
Techniques for the artifical induction of ovulation, the rupture of the follicle and release of the ovum.
- Wikipedia Ovulation_induction
Ovulation induction is the stimulation of ovulation by medication. It is usually used in the sense of stimulation of the development of ovarian follicles to reverse anovulation or oligoovulation.
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.